Skip to content
Submit incident
AII-1000-41437
ConfirmedA court, a regulator or the organization itself has stated the core facts, or the record cites a court or regulator source.

AI-designed bacteriophage genomes raise biosecurity concerns

Researchers at Stanford University and the Arc Institute used AI to design functional bacteriophage genomes, including 16 that were synthesised and tested successfully in laboratories. The development raises biosecurity concerns about potential misuse of AI-designed viruses that could evade detection systems.

6 August 2026 ยท Stanford University ยท Security and cyberattacks
6 August 2026
AII-1000-414372 sources โ†“
Quick facts
Category
Security and cyberattacks
Country
United States
Source
Forbes
Date
6 August 2026
Drafted by
Raidu Incident Detection

What happened

Researchers at Stanford University and the Arc Institute used generative AI models Evo 1 and Evo 2 to design complete genomes of bacteriophagesโ€”viruses that infect bacteria. Of 285 AI-generated designs, researchers synthesised and tested nearly 300 candidate genomes in the laboratory, resulting in 16 functioning phages that successfully infected and killed E. coli.

The AI-designed bacteriophages represent the first functional genomes composed by machine that have not been found in nature. Some of the designed phages were able to overcome bacterial resistance that defeated the original virus.

Reported impact

Experts noted that AI has entered the design stage of biology, which raises biosecurity concerns. One AI researcher described a potential threat of 'deepfake viruses'โ€”viruses re-engineered by AI to maintain dangerous functions while rearranging genetic sequences to evade existing detection and screening systems.

Index analysis

The Stanford experiment demonstrates that computers are moving from analysing biological information towards proposing biological designs that scientists can physically build. While the creation of viral genomes and deliberate modification of viruses is not new to science, the use of AI to autonomously design functional novel viral genomes at scale represents a new capability in the field.

Governance controls

Experts noted that the development of AI-guided viral genome design requires appropriate governance and safeguards.

Classification

Category
Security and cyberattacks
Industry
Healthcare, drugs and biotechnology
Country
United States
Harm status
Potential harm
Intent
Unintentional
Timing
Unknown
Harm types
Public interest
Consequences
None recorded
AI systems
Evo 1, Evo 2

Sources and evidence

This record was researched and written by the Index, based on the following original reporting.

Forbes
AI Can Now Make Deepfake Biological Viruses. We Are Not Prepared
13 August 2026
The Hindu
What happens when AI begins to design viruses?
13 August 2026